← Back to Search

Cognitive Training

Cognitive remediation and Behavioral Intervention for Attention Deficit Hyperactivity Disorder (ADHD)

Phase 2
Waitlist Available
Led By Anil Chacko, PhD
Research Sponsored by Queens College, The City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
- Diagnosis of ADHD Children 7-11 year olds English Speaking
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month follow up
Awards & highlights

Summary

The objective of this study is to evaluate a novel sequenced combination of a promising, computerized cognitive training program targeting working memory (WM) deficits in children with attention-deficit/hyperactivity disorder (ADHD) in combination with behavioral parent training, a well-established, evidence-based intervention for ADHD. The combined active intervention, compared to the combined control intervention will result in improvement in primary psychosocial (i.e., parent/teacher reported child impairment; parental stress; parenting behavior; and observed child academic achievement) and psychiatric (parent/teacher rated ADHD, ODD, and CD symptoms; observed activity level and attention) outcomes at post-treatment and follow up assessment, with the combined active intervention resulting in greater improvements in these outcomes.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
ADHD Symptoms
Academic Achievement
CD symptoms
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Cognitive remediation and Behavioral InterventionExperimental Treatment1 Intervention
Group II: Low Level Cognitive Remediation and Behavioral Parent TraningPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Queens College, The City University of New YorkLead Sponsor
12 Previous Clinical Trials
11,203 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
82 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Anil Chacko, PhDPrincipal InvestigatorQueens College, The City University of New York
4 Previous Clinical Trials
300 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
60 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
~5 spots leftby Oct 2025